Valuation: Lonza Group AG

Capitalization 38.15B 47.37B 40.72B 35.56B 65.68B 4,264B 71.44B 446B 172B 2,014B 178B 174B 7,363B P/E ratio 2025 *
37.8x
P/E ratio 2026 * 31.1x
Enterprise value 41.58B 51.63B 44.39B 38.76B 71.58B 4,647B 77.86B 486B 188B 2,195B 194B 190B 8,025B EV / Sales 2025 *
5.5x
EV / Sales 2026 * 5.02x
Free-Float
93.86%
Yield 2025 *
0.92%
Yield 2026 * 1.04%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.75%
1 week-0.66%
Current month-1.24%
1 month+0.59%
3 months-6.05%
6 months-3.35%
Current year+1.38%
More quotes
1 week 542.8
Extreme 542.8
565
1 month 523.8
Extreme 523.8
565
Current year 467.8
Extreme 467.8
616
1 year 467.8
Extreme 467.8
616
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 133.5
Extreme 133.5
785.4
More quotes
Manager TitleAgeSince
Chief Executive Officer 53 30/06/2024
Director of Finance/CFO 53 30/11/2021
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 15/04/2014
Director/Board Member 67 15/04/2014
Director/Board Member 66 25/04/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.95%-0.66%+2.80%+7.78% 48.03B
+0.12%-2.19%+12.53%+6.16% 38.3B
-2.77%-5.65%+59.36%+70.29% 36.67B
+0.38%-1.03%+9.38%+19.64% 27.13B
+0.03%-8.64%+58.13%+163.39% 15.35B
+1.54%+1.92%+67.55%+225.86% 15.17B
+0.20%+0.42%-11.32%-9.27% 14.19B
+0.55%-1.84%+43.90% - 13.58B
-0.04%-1.71%+121.27%+108.61% 13.25B
-1.45%-3.29%+55.48%+71.95% 12.74B
Average -0.22%-1.75%+41.91%+73.82% 23.44B
Weighted average by Cap. -0.46%-1.69%+32.90%+53.79%
See all sector performances

Financials

2025 *2026 *
Net sales 7.56B 9.39B 8.07B 7.04B 13.01B 845B 14.15B 88.41B 34.14B 399B 35.23B 34.48B 1,459B 8.29B 10.3B 8.85B 7.73B 14.28B 927B 15.53B 97.01B 37.46B 438B 38.66B 37.83B 1,601B
Net income 1.03B 1.28B 1.1B 957M 1.77B 115B 1.92B 12.01B 4.64B 54.22B 4.79B 4.69B 198B 1.24B 1.54B 1.33B 1.16B 2.14B 139B 2.33B 14.55B 5.62B 65.64B 5.8B 5.67B 240B
Net Debt 3.43B 4.26B 3.66B 3.2B 5.91B 383B 6.42B 40.13B 15.5B 181B 15.99B 15.65B 662B 3.49B 4.33B 3.73B 3.25B 6.01B 390B 6.54B 40.83B 15.77B 184B 16.27B 15.92B 674B
More financial data * Estimated data
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - bio-pharmaceuticals (57.4%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.; - capsules and dosing solutions for biopharmaceuticals, drugs and nutrition products (16.5%). In addition, the group offers nutritional ingredients; - small molecule drug substances (15.3%); - technologies and platforms for manufacturing processes and production of cell and gene therapies (10.8%).
Employees
19,299
More about the company
Date Price Change Volume
05/12/25 543.20 CHF -0.95% 156,610
04/12/25 548.40 CHF -0.94% 113,264
03/12/25 553.60 CHF -0.07% 93,233
02/12/25 554.00 CHF -0.22% 126,485
01/12/25 555.20 CHF +0.95% 125,875

Delayed Quote Swiss Exchange, December 05, 2025 at 04:30 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
543.20CHF
Average target price
679.14CHF
Spread / Average Target
+25.03%
Consensus

Quarterly revenue - Rate of surprise